Medical - Devices
Compare Stocks
2 / 10Stock Comparison
POAS vs CLFD
Revenue, margins, valuation, and 5-year total return — side by side.
Communication Equipment
POAS vs CLFD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Communication Equipment |
| Market Cap | $32M | $519M |
| Revenue (TTM) | $2M | $136M |
| Net Income (TTM) | $-2M | $-9M |
| Gross Margin | 47.7% | 37.2% |
| Operating Margin | -132.9% | 1.4% |
| Forward P/E | — | 75.9x |
| Total Debt | $793K | $9M |
| Cash & Equiv. | $2M | $21M |
Quick Verdict: POAS vs CLFD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
POAS is the clearest fit if your priority is income & stability and growth exposure.
- beta 0.10
- Rev growth 189.3%, EPS growth 100.0%
- Lower volatility, beta 0.10, Low D/E 27.1%, current ratio 2.31x
CLFD carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 106.7% 10Y total return vs POAS's -39.5%
- -6.3% margin vs POAS's -125.3%
- +20.2% vs POAS's -39.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 189.3% revenue growth vs CLFD's 19.6% | |
| Quality / Margins | -6.3% margin vs POAS's -125.3% | |
| Stability / Safety | Beta 0.10 vs CLFD's 1.79 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +20.2% vs POAS's -39.5% | |
| Efficiency (ROA) | -3.0% ROA vs POAS's -71.9% |
POAS vs CLFD — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CLFD leads this category, winning 3 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
CLFD is the larger business by revenue, generating $136M annually — 72.4x POAS's $2M. CLFD is the more profitable business, keeping -6.3% of every revenue dollar as net income compared to POAS's -125.3%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2M | $136M |
| EBITDAEarnings before interest/tax | — | $6M |
| Net IncomeAfter-tax profit | — | -$9M |
| Free Cash FlowCash after capex | — | $15M |
| Gross MarginGross profit ÷ Revenue | +47.7% | +37.2% |
| Operating MarginEBIT ÷ Revenue | -132.9% | +1.4% |
| Net MarginNet income ÷ Revenue | -125.3% | -6.3% |
| FCF MarginFCF ÷ Revenue | -91.9% | +10.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -27.1% |
| EPS Growth (YoY)Latest quarter vs prior year | — | -142.5% |
Valuation Metrics
CLFD leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $32M | $519M |
| Enterprise ValueMkt cap + debt − cash | $31M | $506M |
| Trailing P/EPrice ÷ TTM EPS | — | -64.64x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 75.91x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 61.46x |
| Price / SalesMarket cap ÷ Revenue | 21.50x | 3.46x |
| Price / BookPrice ÷ Book value/share | — | 2.05x |
| Price / FCFMarket cap ÷ FCF | — | 21.01x |
Profitability & Efficiency
CLFD leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
CLFD delivers a -3.4% return on equity — every $100 of shareholder capital generates $-3 in annual profit, vs $-81 for POAS. CLFD carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to POAS's 0.27x. On the Piotroski fundamental quality scale (0–9), CLFD scores 7/9 vs POAS's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -80.8% | -3.4% |
| ROA (TTM)Return on assets | -71.9% | -3.0% |
| ROICReturn on invested capital | — | +0.6% |
| ROCEReturn on capital employed | -6.5% | +0.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.27x | 0.03x |
| Net DebtTotal debt minus cash | -$2M | -$13M |
| Cash & Equiv.Liquid assets | $2M | $21M |
| Total DebtShort + long-term debt | $792,580 | $9M |
| Interest CoverageEBIT ÷ Interest expense | -57.49x | 85.32x |
Total Returns (Dividends Reinvested)
CLFD leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CLFD five years ago would be worth $9,591 today (with dividends reinvested), compared to $6,052 for POAS. Over the past 12 months, CLFD leads with a +20.2% total return vs POAS's -39.5%. The 3-year compound annual growth rate (CAGR) favors CLFD at 1.3% vs POAS's -15.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -26.3% | +27.1% |
| 1-Year ReturnPast 12 months | -39.5% | +20.2% |
| 3-Year ReturnCumulative with dividends | -39.5% | +3.9% |
| 5-Year ReturnCumulative with dividends | -39.5% | -4.1% |
| 10-Year ReturnCumulative with dividends | -39.5% | +106.7% |
| CAGR (3Y)Annualised 3-year return | -15.4% | +1.3% |
Risk & Volatility
Evenly matched — POAS and CLFD each lead in 1 of 2 comparable metrics.
Risk & Volatility
POAS is the less volatile stock with a 0.10 beta — it tends to amplify market swings less than CLFD's 1.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CLFD currently trades 80.2% from its 52-week high vs POAS's 31.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.14x | 1.74x |
| 52-Week HighHighest price in past year | $7.39 | $46.76 |
| 52-Week LowLowest price in past year | $0.53 | $24.01 |
| % of 52W HighCurrent price vs 52-week peak | +31.5% | +80.2% |
| RSI (14)Momentum oscillator 0–100 | 60.7 | 57.1 |
| Avg Volume (50D)Average daily shares traded | 376K | 146K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $43.33 |
| # AnalystsCovering analysts | — | 8 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +7.1% | +3.2% |
CLFD leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.
POAS vs CLFD: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is POAS or CLFD a better buy right now?
For growth investors, Phaos Technology Holdings (Cayman) Limited (POAS) is the stronger pick with 189.
3% revenue growth year-over-year, versus 19. 6% for Clearfield, Inc. (CLFD). Analysts rate Clearfield, Inc. (CLFD) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — POAS or CLFD?
Over the past 5 years, Clearfield, Inc.
(CLFD) delivered a total return of -4. 1%, compared to -39. 5% for Phaos Technology Holdings (Cayman) Limited (POAS). Over 10 years, the gap is even starker: CLFD returned +120. 7% versus POAS's -37. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — POAS or CLFD?
By beta (market sensitivity over 5 years), Phaos Technology Holdings (Cayman) Limited (POAS) is the lower-risk stock at 0.
14β versus Clearfield, Inc. 's 1. 74β — meaning CLFD is approximately 1129% more volatile than POAS relative to the S&P 500. On balance sheet safety, Clearfield, Inc. (CLFD) carries a lower debt/equity ratio of 3% versus 27% for Phaos Technology Holdings (Cayman) Limited — giving it more financial flexibility in a downturn.
04Which is growing faster — POAS or CLFD?
By revenue growth (latest reported year), Phaos Technology Holdings (Cayman) Limited (POAS) is pulling ahead at 189.
3% versus 19. 6% for Clearfield, Inc. (CLFD). On earnings-per-share growth, the picture is similar: Phaos Technology Holdings (Cayman) Limited grew EPS 100. 0% year-over-year, compared to 31. 8% for Clearfield, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — POAS or CLFD?
Clearfield, Inc.
(CLFD) is the more profitable company, earning -5. 4% net margin versus -125. 3% for Phaos Technology Holdings (Cayman) Limited — meaning it keeps -5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLFD leads at 1. 4% versus -132. 9% for POAS. At the gross margin level — before operating expenses — POAS leads at 47. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — POAS or CLFD?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is POAS or CLFD better for a retirement portfolio?
For long-horizon retirement investors, Phaos Technology Holdings (Cayman) Limited (POAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
14)). Clearfield, Inc. (CLFD) carries a higher beta of 1. 74 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (POAS: -37. 9%, CLFD: +120. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between POAS and CLFD?
These companies operate in different sectors (POAS (Healthcare) and CLFD (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.